Prestige Consumer SVP trades around stock awards

Prestige Consumer Healthcare Senior VP of Operations Jeffrey Zerillo reported routine equity compensation activity and a small share sale.

Rhea-AI Filing Summary

Prestige Consumer Healthcare Senior VP of Operations Jeffrey Zerillo reported routine equity compensation activity and a small share sale. He received stock awards of 2,857 and 2,450 common shares at no cost, reflecting PSU settlement and RSU grants. To cover tax obligations, 1,243 shares were disposed of, and he later sold 346 shares in an open-market transaction at about $55.32 per share. After these transactions, he directly holds 44,334 shares of Prestige Consumer Healthcare common stock.

Insider Trade Summary 10b5-1

Net Seller: 346 shares

Net Sell 4 txns

Insider Zerillo Jeffrey

Role Senior VP Operations

Sold 346 shs ($19K)

Type	Security	Shares	Price	Value
Sale	Common Stock, par value $0.01 per share	346	$55.32	$19K
Grant/Award	Common Stock, par value $0.01 per share	2,450	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock, par value $0.01 per share	1,243	$55.31	$69K
Grant/Award	Common Stock, par value $0.01 per share	2,857	$0.00	$0.00

Holdings After Transaction: Common Stock, par value $0.01 per share — 44,334 shares (Direct)

Footnotes (2)

1. F1. Reflects the settlement of performance stock units ("PSUs") granted to the reporting person on May 5, 2023, which PSUs vested on May 4, 2026 based on achievement of goals related to per share growth.
2. F2. The Restricted Stock Units in three installments of 952 shares each on May 4, 2027 and May 4, 2028 and 953 shares on May 4, 2029.

Key Figures

Open-market sale: 346 shares at $55.32/share Equity award 1: 2,857 shares at $0.00 Equity award 2: 2,450 shares at $0.00 +2 more

5 metrics

Open-market sale 346 shares at $55.32/share Common stock sale on 2026-05-05

Equity award 1 2,857 shares at $0.00 Grant/award acquisition on 2026-05-04

Equity award 2 2,450 shares at $0.00 Grant/award acquisition on 2026-05-04

Tax-withholding shares 1,243 shares at $55.31/share Tax-withholding disposition on 2026-05-04

Shares held after transactions 44,334 shares Direct ownership after 2026-05-05 sale

Key Terms

performance stock units ("PSUs"), Restricted Stock Units, tax-withholding disposition, open-market sale

4 terms

performance stock units ("PSUs") financial

"Reflects the settlement of performance stock units ("PSUs") granted to the reporting person"

Restricted Stock Units financial

"The Restricted Stock Units in three installments of 952 shares each"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax-withholding disposition financial

"transaction_action": "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Prestige Consumer Healthcare (PBH) executive Jeffrey Zerillo report in this Form 4?

Senior VP Operations Jeffrey Zerillo reported stock awards and a small sale. He received 2,857 and 2,450 common shares as equity grants, had 1,243 shares withheld for taxes, and sold 346 shares in the open market, ending with 44,334 shares owned.

How many Prestige Consumer Healthcare (PBH) shares does Jeffrey Zerillo hold after these transactions?

Following the reported transactions, Jeffrey Zerillo directly holds 44,334 shares of Prestige Consumer Healthcare common stock. This figure comes after stock awards, tax-withholding share dispositions, and a 346-share open-market sale disclosed in the Form 4 filing.

What stock awards did Jeffrey Zerillo receive from Prestige Consumer Healthcare (PBH)?

Jeffrey Zerillo received two non-cash stock awards totaling 5,307 shares of Prestige Consumer Healthcare common stock, in blocks of 2,857 and 2,450 shares. Footnotes describe settlement of performance stock units and restricted stock units vesting over future dates.

Was the share sale by Prestige Consumer Healthcare (PBH) executive Jeffrey Zerillo large?

The reported sale was relatively small at 346 shares at about $55.32 per share. Compared with his post-transaction holding of 44,334 shares, the sale represents only a minor portion of his overall direct stake in Prestige Consumer Healthcare.

Why were some Prestige Consumer Healthcare (PBH) shares disposed of for Jeffrey Zerillo?

The Form 4 shows a disposition of 1,243 shares coded as a tax-withholding transaction. This reflects shares delivered to cover tax liabilities arising from equity awards, rather than an open-market sale initiated for portfolio or valuation reasons.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/06/2026 - 05:16 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zerillo Jeffrey

(Last) (First) (Middle)

660 WHITE PLAINS ROAD

(Street)

TARRYTOWN NEW YORK 10591

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Prestige Consumer Healthcare Inc. [ PBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior VP Operations

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	05/04/2026		A		2,450(1)	A	$0	43,066	D
Common Stock, par value $0.01 per share	05/04/2026		F		1,243	D	$55.31	41,823	D
Common Stock, par value $0.01 per share	05/04/2026		A(2)		2,857	A	$0	44,680	D
Common Stock, par value $0.01 per share	05/05/2026		S		346	D	$55.32	44,334	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the settlement of performance stock units ("PSUs") granted to the reporting person on May 5, 2023, which PSUs vested on May 4, 2026 based on achievement of goals related to per share growth.

2. The Restricted Stock Units in three installments of 952 shares each on May 4, 2027 and May 4, 2028 and 953 shares on May 4, 2029.

	/s/ Jeffrey Zerillo by William P'Pool as attorney-in-fact pursuant to power of attorney dated August 7, 2018 on file with the Commission	05/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)